keyword
https://read.qxmd.com/read/38654565/the-association-of-chads-p2a2rc-risk-score-with-clinical-outcomes-in-patients-taking-p2y12-inhibitor-monotherapy-after-3-months-of-dual-antiplatelet-therapy-following-percutaneous-coronary-intervention
#1
JOURNAL ARTICLE
Pil Sang Song, Seok-Woo Seong, Ji-Yeon Kim, Soo Yeon An, Mi Joo Kim, Kye Taek Ahn, Seon-Ah Jin, Jin-Ok Jeong, Jeong Hoon Yang, Joo-Yong Hahn, Hyeon-Cheol Gwon, Woo Jin Jang, Hyuck Jun Yoon, Jang-Whan Bae, Woong Gil Choi, Young Bin Song
BACKGROUND AND OBJECTIVES: Concerns remain that early aspirin cessation may be associated with potential harm in subsets at high risk of ischemic events. This study aimed to assess the effects of P2Y12 inhibitor monotherapy after 3-month dual antiplatelet therapy (DAPT) vs. prolonged DAPT (12-month or longer) based on the ischemic risk stratification, the CHADS-P2A2RC, after percutaneous coronary intervention (PCI). METHODS: This was a sub-study of the SMART-CHOICE trial...
April 2024: Korean Circulation Journal
https://read.qxmd.com/read/38652559/pro-thrombotic-autoantibodies-targeting-platelet-factor-4-polyanion-are-associated-with-pediatric-cerebral-malaria
#2
JOURNAL ARTICLE
Iset M Vera, Anne Kessler, Visopo Harawa, Ajisa Ahmadu, Thomas E Keller, Stephen Tj Ray, Terrie E Taylor, Stephen J Rogerson, Wilson L Mandala, Morayma Reyes Gil, Karl B Seydel, Kami Kim
BACKGROUND: Features of consumptive coagulopathy and thromboinflammation are prominent in cerebral malaria (CM). We hypothesized that thrombogenic autoantibodies contribute to a procoagulant state in CM. METHODS: Plasma from children with uncomplicated malaria (UM, n = 124) and CM (n = 136) was analyzed by ELISA for a panel of 8 autoantibodies including anti-Platelet Factor 4/polyanion (anti-PF4/P), anti-Phospholipid, anti-Phosphatidylserine, anti-Myeloperoxidase, anti-Proteinase 3, anti-dsDNA, anti-Beta-2-Glycoprotein I (β2GPI), and anti-Cardiolipin...
April 23, 2024: Journal of Clinical Investigation
https://read.qxmd.com/read/38644062/platelet-function-testing-update-on-determinant-variables-and-permissive-windows-using-a-platelet-count-based-device
#3
REVIEW
Patricia Villar, Sofía Carreño, Sara Moro, Inés Díez Galindo, Ángel Bernardo, Laura Gutiérrez
While there are various aspects of platelet biology that can be studied in the lab (i.e. adhesion, degranulation, integrin activation), the master test for platelet function is that which gives a measure of the platelet aggregation capacity upon stimulation with an agonist. Platelet function testing is necessary for the diagnosis of platelet disorders and the monitoring of patients receiving anti-platelet treatments. Furthermore, it becomes relevant in the quality control of platelet concentrates for transfusion purposes, especially considering the global concern about long term storage, other forms of storage (i...
April 18, 2024: Transfusion and Apheresis Science
https://read.qxmd.com/read/38641310/direct-contact-between-tumor-cells-and-platelets-initiates-a-fak-dependent-f3-tgf-%C3%AE-positive-feedback-loop-that-promotes-tumor-progression-and-emt-in-osteosarcoma
#4
JOURNAL ARTICLE
Qianyu Shi, Jiuhui Xu, Chenglong Chen, Xueyu Hu, Boyang Wang, Fanwei Zeng, Tingting Ren, Yi Huang, Wei Guo, Xiaodong Tang, Tao Ji
Platelets have received growing attention for their roles in hematogenous tumor metastasis. However, the tumor-platelet interaction in osteosarcoma (OS) remains poorly understood. Here, using platelet-specific focal adhesion kinase (FAK)-deficient mice, we uncover a FAK-dependent F3/TGF-β positive feedback loop in OS. Disruption of the feedback loop by inhibition of F3, TGF-β, or FAK significantly suppresses OS progression. We demonstrate that OS F3 initiated the feedback loop by increasing platelet TGF-β secretion, and platelet-derived TGF-β promoted OS F3 expression in turn and modulated OS EMT process...
April 17, 2024: Cancer Letters
https://read.qxmd.com/read/38617912/a-chinese-classical-prescription-xuefu-zhuyu-decoction-in-the-treatment-of-coronary-heart-disease-an-overview
#5
REVIEW
Xuezhen Wang, Xunyan Xing, Peifeng Huang, Zhibin Zhang, Zehua Zhou, Leiqin Liang, Rongmei Yao, Xuerun Wu, Long Yang
BACKGROUND: Coronary heart disease (CHD) is the leading cause of morbidity and mortality worldwide and is a hot topic in cardiovascular disease research. Western medicine treats CHD with stent implantation, anti-angina pectoris, anti-platelet aggregation and other operations or drugs. According to the whole concept and the characteristics of syndrome differentiation, traditional Chinese medicine (TCM) treats CHD according to different syndromes and points out that qi deficiency and blood stasis are the basic pathogenesis of CHD...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38599489/bailout-distal-internal-carotid-artery-stenting-after-carotid-endarterectomy-indications-technique-and-outcomes
#6
JOURNAL ARTICLE
Michael A Ciaramella, Patric Liang, Allen D Hamdan, Mark C Wyers, Marc L Schermerhorn, Lars Stangenberg
OBJECTIVE: Distal internal carotid artery (ICA) stenting may be employed as a bailout maneuver when an inadequate endpoint or clamp injury is encountered at the time of carotid endarterectomy (CEA) in a surgically inaccessible region of the distal ICA. We sought to characterize the indications, technique, and outcomes for this infrequently encountered clinical scenario. METHODS: We performed a retrospective review of all patients who underwent distal ICA stenting at the time of CEA at our institution between September, 2008 and July, 2022...
April 8, 2024: Annals of Vascular Surgery
https://read.qxmd.com/read/38594599/improving-outcomes-in-atherosclerotic-renovascular-disease-importance-of-clinical-presentation-and-multi-disciplinary-review
#7
JOURNAL ARTICLE
Áine M de Bhailis, Edward Lake, Constantina Chrysochou, Darren Green, Rajkumar Chinnadurai, Philip A Kalra
BACKGROUND AND OBJECTIVES: Atherosclerotic renal artery stenosis may cause hypertension, chronic kidney disease and heart failure, but large randomized control trials to date have shown no major additional benefit of renal revascularization over optimal medical management. However, these trials did not consider outcomes specifically in relation to clinical presentations. Given that atherosclerotic renal artery stenosis is a heterogenous condition, measures of success likely differ according to the clinical presentation...
April 9, 2024: Journal of Nephrology
https://read.qxmd.com/read/38590689/analysis-and-identification-of-putative-novel-peptides-purified-from-iranian-endemic-echis-carinatus-sochureki-snake-venom-by-maldi-tof-mass-spectrometry
#8
JOURNAL ARTICLE
Nasri Nasrabadi Nafiseh, Vatanpour Hossein, Mohammadpour Dounighi Nasser, Najafi Mojtaba, Ahmadinejad Minoo, Bayatzadeh Mohammad Ali, Pouyanmehr Giti
The Iranian Echis Carinatus (IEC) venom is an exclusive natural source of bio-substances for a wide range of purposes in the blood coagulation cascade. The present study for the first time was aimed to assess novel pro-coagulant, anti-coagulant and anti-platelet proteins, named EC1.5 (a) , EC5.1 (b) and EC4 (a) from Iranian Echis Carinatus (IEC) venom. These peptides were purified by multi-step chromatography methods. Hematological properties were measured using activated clotting tests, platelet aggregation studies, and hemorrhage assessment...
October 2023: Archives of Razi Institute
https://read.qxmd.com/read/38586911/essential-thrombocythaemia-a-contemporary-approach-with-new-drugs-on-the-horizon
#9
REVIEW
Francisca Ferrer-Marín, Juan Carlos Hernández-Boluda, Alberto Alvarez-Larrán
Essential thrombocythaemia (ET) is a myeloproliferative neoplasm characterized by an increased risk of vascular complications and a tendency to progress to myelofibrosis and acute leukaemia. ET patients have traditionally been stratified into two thrombosis risk categories based on age older than 60 years and a history of thrombosis. More recently, the revised IPSET-thrombosis scoring system, which accounts for the increased risk linked to the JAK2 mutation, has been incorporated into most expert recommendations...
April 8, 2024: British Journal of Haematology
https://read.qxmd.com/read/38570147/dryopteris-crassirhizoma-nakai-a-review-of-its-botany-traditional-use-phytochemistry-pharmacological-activity-toxicology-and-pharmacokinetics
#10
REVIEW
Qian-Xiang Bai, Zhao-Jiong Zhang, Hai-Peng Tang, Yang Liu, Bing-You Yang, Hai-Xue Kuang, Meng Wang
ETHNOPHARMACOLOGICAL RELEVANCE: The Dryopteris crassirhizoma Nakai., a commonly used herb, is known as "Guan Zhong" in China, "Oshida" in Japan and "Gwanjung" in Korea. It has long been used for parasitic infestation, hemorrhages and epidemic influenza. AIM OF THE REVIEW: The present paper aims to provide an up-to-date review at the advancements of the investigations on the traditional use, phytochemistry, pharmacological activity, toxicology and pharmacokinetics of D...
April 1, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38550469/twists-and-turns-a-chiropractic-roller-coaster-experience-unraveling-the-intricacies-of-bilateral-vertebral-artery-dissection
#11
Satori Iwamoto, Megan D Hsu, An Phuc D Ta, Alexis Leo, Harrison Chu, Gary Chu
The primary insult in vertebral artery dissections (VADs) involves a tear in the vertebral artery intima, resulting in potential thrombus formation and an elevated risk of cerebrovascular events, such as stroke. Despite its relatively low overall incidence rate, VADs contribute to a significant proportion of ischemic strokes within the younger population. VAD has been associated with various risk factors including but not limited to neck trauma from chiropractic manipulation and significant neck movements. Our patient initially presented with a worsening occipital headache but was discharged due to the absence of any red-flag symptoms...
February 2024: Curēus
https://read.qxmd.com/read/38544974/impact-of-platelet-hyperreactivity-and-diabetes-mellitus-on-ischemic-stroke-recurrence-a-single-center-cohort-clinical-study
#12
JOURNAL ARTICLE
Yusheng Mao, Bangqiang Zhu, Huiqin Wen, Tao Zhong, Maohong Bian
PURPOSE: Ischemic stroke recurrence (ISR) is prevented by inhibiting platelet function. To investigate the impact of high on-treatment platelet reactivity (HTPR) assessed by thromboelastography (TEG) and its risk factors on ISR in individuals who have experienced acute ischemic stroke (AIS) receiving dual anti-platelet therapy (DAPT). PATIENTS AND METHODS: At the end of follow-up, a total of 264 patients who met the criteria were enrolled in this cohort study. The primary endpoint event was a recurrence of ischemic stroke within 90 days of onset...
2024: International Journal of General Medicine
https://read.qxmd.com/read/38539489/the-clinical-value-of-pre-diagnostic-thrombocytosis-for-the-detection-of-lung-cancer-in-primary-care
#13
JOURNAL ARTICLE
Melissa Barlow, Willie Hamilton, Sarah E R Bailey
Thrombocytosis is a risk marker for lung cancer in primary care. We investigated whether thrombocytosis presents pre-diagnostically for all the histological subtypes of lung cancer and its association with the stage at diagnosis. A matched cohort study used English electronic primary care data linked to the national cancer registry. Patients diagnosed with lung cancer aged ≥40 years with no prior history of malignancy were matched by age, sex, and general practice to five controls without lung cancer...
March 14, 2024: Cancers
https://read.qxmd.com/read/38533262/new-light-on-changes-in-the-number-and-function-of-blood-platelets-stimulated-by-cocoa-and-its-products
#14
REVIEW
Beata Olas
Hyperactivation of blood platelets, one of the causes of heart attack, and other cardiovascular diseases (CVDs), is influenced by various dietary components, including phenolic compounds from vegetables, fruits, teas, wines, cocoa and its products, including chocolate. The present paper sheds new light on the effect of cocoa and its products, especially dark chocolate, on the number and function of blood platelets, and the anti-platelet activity of their constituent phenolic compounds. A review was performed of papers identified in various electronic databases, including PubMed, Science Direct, Scopus, Web of Knowledge, and Google Scholar, with the aim of determining whether their anti-platelet activity may serve as part of a sweet strategy in countering CVDs...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38504170/ticagrelor-monotherapy-after-a-short-course-of-dual-antiplatelet-therapy-with-ticagrelor-plus-aspirin-following-percutaneous-coronary-intervention-in-patients-with-versus-without-diabetes-mellitus-a-meta-analysis-of-randomized-trials
#15
JOURNAL ARTICLE
Chen Ning, Fang Ling, Deyi Liu, Zhang Zhi
BACKGROUND: Cardiovascular disease (CVD) is one among the major causes of mortality all round the globe. Several anti-platelet regimens have been proposed following percutaneous coronary intervention (PCI). In this analysis, we aimed to show the adverse clinical outcomes associated with ticagrelor monotherapy after a short course of dual antiplatelet therapy (DAPT) with ticagrelor and aspirin following PCI in patients with versus without diabetes mellitus (DM). METHODS: Electronic databases were searched by four authors from September to November 2023...
March 19, 2024: BMC Cardiovascular Disorders
https://read.qxmd.com/read/38500074/triple-platelet-inhibition-in-intracranial-thrombectomy-with-additional-acute-cervical-stent-angioplasty-due-to-tandem-lesion-a-retrospective-single-center-analysis
#16
JOURNAL ARTICLE
Ali Khanafer, Hans Henkes, Philipp Bücke, Florian Hennersdorf, Hansjörg Bäzner, Michael Forsting, Philipp von Gottberg
BACKGROUND: Acute stroke treatment with intracranial thrombectomy and treatment of ipsilateral carotid artery stenosis/occlusion ("tandem lesion", TL) in one session is considered safe. However, the risk of stent restenosis after TL treatment is high, and antiplatelet therapy (APT) preventing restenosis must be well balanced to avoid intracranial hemorrhage. We investigated the safety and 90-day outcome of patients receiving TL treatment under triple-APT, focused on stent-patency and possible disadvantageous comorbidities...
March 18, 2024: BMC Neurology
https://read.qxmd.com/read/38489091/aspirin-responsiveness-in-a-cohort-of-pediatric-patients-with-right-ventricle-to-pulmonary-artery-conduits-and-transcatheter-valve-replacement-systems
#17
JOURNAL ARTICLE
Sean T Kelleher, Irene E Regan, Dermot Cox, Kathryn Shaw, Orla Franklin, Damien P Kenny, Kevin P Walsh, Colin J McMahon
The aim of this study was to determine the rate of aspirin responsiveness in a cohort of pediatric patients with in situ xenograft valved right ventricle to pulmonary artery (RV-PA) conduits and/or transcatheter valve replacements (TVR). Aspirin is routinely prescribed to these patients. Optimizing anti-platelet therapy could promote valve longevity and reduce the risk of infective endocarditis in this at-risk group. This was a prospective, observational study. Patients were recruited from both ward and outpatient settings...
March 15, 2024: Pediatric Cardiology
https://read.qxmd.com/read/38487715/optimal-p2y-12-inhibitor-durations-in-older-men-and-older-women-following-an-acute-myocardial-infarction-a-nationwide-cohort-study-using-medicare-data
#18
JOURNAL ARTICLE
Ryan P Hickson, Anna M Kucharska-Newton, Jo E Rodgers, Betsy L Sleath, Gang Fang
STUDY OBJECTIVE: Identify optimal P2Y12 inhibitor durations balancing ischemic-benefit and bleeding-risk outcomes after acute myocardial infarction (AMI) in older men and women. DESIGN: Observational retrospective cohort with 2 years of follow-up, using clone-censor-weight marginal structural models to emulate randomization. SETTING: 20 % sample of US Medicare administrative claims data. PARTICIPANTS: P2Y12 inhibitor new users ≥66 years old following 2008-2013 AMI hospitalization...
December 2023: American heart journal plus: cardiology research and practice
https://read.qxmd.com/read/38465531/antiplatelet-treatment-preferences-of-a-group-of-cardiologists-from-t%C3%A3-rkiye-a-survey-research-study
#19
JOURNAL ARTICLE
Özge Çetinarslan, Mustafa Yenerçağ, Mehdi Zoghi, Asım Oktay Ergene
OBJECTIVE: Deciding on the optimal duration of dual antiplatelet treatment (DAPT) remains a complex decision. This survey aims to explore the preferences for antiplatelet therapy and the daily routine regarding DAPT duration in coronary artery disease among a group of cardiologists in Türkiye. METHOD: Using an online questionnaire with 38 questions, the preferences of 314 cardiologists were collected. Qualitative descriptive characteristics of the answers received from the participants were examined...
March 2024: Türk Kardiyoloji Derneği Arşivi: Türk Kardiyoloji Derneğinin Yayın Organıdır
https://read.qxmd.com/read/38453424/gpvi-as-an-effective-antithrombotic-target
#20
JOURNAL ARTICLE
Alexandre Slater, Sophia Khattak, Mark R Thomas
Glycoprotein (GP) VI plays a major role in thrombosis but not haemostasis, making it a promising antithrombotic target. The primary role of GPVI on the surface of platelets is a signalling receptor for collagen, which is one of the most potent thrombotic sub-endothelial components that is exposed by atherosclerotic plaque rupture. Inhibition of GPVI has therefore been investigated as a strategy for treatment and prevention of atherothrombosis, such as during stroke and acute coronary syndromes. A range of specific GPVI inhibitors have been characterised and 2 of these inhibitors, glenzocimab and revacept, have completed phase II clinical trials in ischemic stroke...
March 7, 2024: European Heart Journal. Cardiovascular Pharmacotherapy
keyword
keyword
12157
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.